Literature DB >> 33937566

SARS-CoV-2 surreptitiously injures the heart of Japanese: echocardiography is useful in evaluating cardiac damage.

Issei Komuro1.   

Abstract

Coronavirus disease 2019 (COVID-19) remains a threat worldwide over a year after the outbreak. Recently, several studies have reported that elevated serum troponin, which reflects myocardial injury, has a significant impact on worsening cardiovascular disease and the death of patients with COVID-19. In addition, magnetic resonance imaging (MRI) and echocardiography revealed abnormal myocardial findings in patients with COVID-19 who have recovered, as exemplified by a slight elevation of high-sensitivity troponin T (hsTnT). This editorial will discuss the impacts of SARS-CoV-2 on the heart of Japanese patients during infection and recovery and future perspectives. 2021, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; echocardiography; myocardial injury; troponin

Year:  2021        PMID: 33937566      PMCID: PMC8071688          DOI: 10.35772/ghm.2021.01035

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  10 in total

1.  Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection.

Authors:  Saurabh Rajpal; Matthew S Tong; James Borchers; Karolina M Zareba; Timothy P Obarski; Orlando P Simonetti; Curt J Daniels
Journal:  JAMA Cardiol       Date:  2021-01-01       Impact factor: 14.676

Review 2.  Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.

Authors:  Yuhui Zhang; Andrew J S Coats; Zhe Zheng; Marianna Adamo; Giuseppe Ambrosio; Stefan D Anker; Javed Butler; Dingli Xu; Jingyuan Mao; Muhammad Shahzeb Khan; Ling Bai; Alexandre Mebazaa; Piotr Ponikowski; Qizhu Tang; Frank Ruschitzka; Petar Seferovic; Carsten Tschöpe; Shuyang Zhang; Chuanyu Gao; Shenghua Zhou; Michele Senni; Jian Zhang; Marco Metra
Journal:  Eur J Heart Fail       Date:  2020-07-13       Impact factor: 15.534

3.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

4.  Global evaluation of echocardiography in patients with COVID-19.

Authors:  Marc R Dweck; Anda Bularga; Rebecca T Hahn; Rong Bing; Kuan Ken Lee; Andrew R Chapman; Audrey White; Giovanni Di Salvo; Leyla Elif Sade; Keith Pearce; David E Newby; Bogdan A Popescu; Erwan Donal; Bernard Cosyns; Thor Edvardsen; Nicholas L Mills; Kristina Haugaa
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-09-01       Impact factor: 6.875

5.  The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis.

Authors:  Jing-Wei Li; Tian-Wen Han; Mark Woodward; Craig S Anderson; Hao Zhou; Yun-Dai Chen; Bruce Neal
Journal:  Prog Cardiovasc Dis       Date:  2020-04-16       Impact factor: 8.194

6.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

7.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

8.  Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography.

Authors:  Omer Faruk Baycan; Hasan Ali Barman; Adem Atici; Adem Tatlisu; Furkan Bolen; Pınar Ergen; Sacit Icten; Baris Gungor; Mustafa Caliskan
Journal:  Int J Cardiovasc Imaging       Date:  2020-08-15       Impact factor: 2.357

9.  Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study.

Authors:  Mats Christian Højbjerg Lassen; Kristoffer Grundtvig Skaarup; Jannie Nørgaard Lind; Alia Saed Alhakak; Morten Sengeløv; Anne Bjerg Nielsen; Caroline Espersen; Kirstine Ravnkilde; Raphael Hauser; Liv Borum Schöps; Eva Holt; Niklas Dyrby Johansen; Daniel Modin; Kasper Djernaes; Claus Graff; Henning Bundgaard; Christian Hassager; Reza Jabbari; Jørn Carlsen; Anne-Mette Lebech; Ole Kirk; Uffe Bodtger; Matias Greve Lindholm; Gowsini Joseph; Lothar Wiese; Frank Vinholt Schiødt; Ole Peter Kristiansen; Emil Schwarz Walsted; Olav Wendelboe Nielsen; Birgitte Lindegaard Madsen; Niels Tønder; Thomas Benfield; Klaus Nielsen Jeschke; Charlotte Suppli Ulrik; Filip Krag Knop; Morten Lamberts; Pradeesh Sivapalan; Gunnar Gislason; Jacob Louis Marott; Rasmus Møgelvang; Gorm Jensen; Peter Schnohr; Peter Søgaard; Scott D Solomon; Kasper Iversen; Jens Ulrik Staehr Jensen; Morten Schou; Tor Biering-Sørensen
Journal:  ESC Heart Fail       Date:  2020-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.